ABDALLAH RAGAB: Open Payments
NPI 1356931968 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 27 payments from 5 companies in 2025. Trend: 2023 $643 · 2024 $333 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $172 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
Products named: VRAYLAR, CAPLYTA, Auvelity, INGREZZA, REXULTI.
Industry payments across NJ — which companies pay providers there.
